Barclays’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.24M | Buy |
216,646
+2,040
| +1% | +$30.5K | ﹤0.01% | 1911 |
|
2025
Q1 | $3.46M | Buy |
214,606
+91,535
| +74% | +$1.48M | ﹤0.01% | 1660 |
|
2024
Q4 | $2.87M | Buy |
123,071
+17,604
| +17% | +$410K | ﹤0.01% | 1978 |
|
2024
Q3 | $3.1M | Buy |
105,467
+41,424
| +65% | +$1.22M | ﹤0.01% | 1863 |
|
2024
Q2 | $1.51M | Buy |
64,043
+18,081
| +39% | +$425K | ﹤0.01% | 1884 |
|
2024
Q1 | $1.74M | Buy |
45,962
+464
| +1% | +$17.6K | ﹤0.01% | 2039 |
|
2023
Q4 | $979K | Buy |
+45,498
| New | +$979K | ﹤0.01% | 2611 |
|
2023
Q3 | – | Sell |
-4
| Closed | – | – | 4380 |
|
2023
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 4410 |
|
2023
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 4415 |
|
2022
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 4515 |
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 4825 |
|
2022
Q2 | $0 | Sell |
4
-262
| -98% | – | ﹤0.01% | 4908 |
|
2022
Q1 | $16K | Sell |
266
-1,700
| -86% | -$102K | ﹤0.01% | 4391 |
|
2021
Q4 | $233K | Buy |
1,966
+1,305
| +197% | +$155K | ﹤0.01% | 2785 |
|
2021
Q3 | $131K | Buy |
661
+434
| +191% | +$86K | ﹤0.01% | 3127 |
|
2021
Q2 | $40K | Sell |
227
-1,291
| -85% | -$227K | ﹤0.01% | 3482 |
|
2021
Q1 | $301K | Buy |
1,518
+929
| +158% | +$184K | ﹤0.01% | 2943 |
|
2020
Q4 | $116K | Sell |
589
-196
| -25% | -$38.6K | ﹤0.01% | 2935 |
|
2020
Q3 | $139K | Sell |
785
-140
| -15% | -$24.8K | ﹤0.01% | 2899 |
|
2020
Q2 | $213K | Buy |
925
+578
| +167% | +$133K | ﹤0.01% | 2779 |
|
2020
Q1 | $41K | Sell |
347
-712
| -67% | -$84.1K | ﹤0.01% | 3184 |
|
2019
Q4 | $202K | Buy |
1,059
+514
| +94% | +$98K | ﹤0.01% | 3169 |
|
2019
Q3 | $105K | Sell |
545
-143
| -21% | -$27.6K | ﹤0.01% | 3381 |
|
2019
Q2 | $118K | Buy |
688
+189
| +38% | +$32.4K | ﹤0.01% | 3502 |
|
2019
Q1 | $100K | Buy |
+499
| New | +$100K | ﹤0.01% | 3341 |
|
2018
Q4 | – | Sell |
-245
| Closed | -$59K | – | 4363 |
|
2018
Q3 | $59K | Buy |
245
+197
| +410% | +$47.4K | ﹤0.01% | 3682 |
|
2018
Q2 | $13K | Sell |
48
-80
| -63% | -$21.7K | ﹤0.01% | 3812 |
|
2018
Q1 | $32K | Buy |
+128
| New | +$32K | ﹤0.01% | 3699 |
|